Načítá se...
Comparing BMD‐derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assay
There is growing interest in quantitative analysis of in vivo genetic toxicity dose‐response data, and use of point‐of‐departure (PoD) metrics such as the benchmark dose (BMD) for human health risk assessment (HHRA). Currently, multiple transgenic rodent (TGR) assay variants, employing different rod...
Uloženo v:
| Vydáno v: | Environ Mol Mutagen |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698699/ https://ncbi.nlm.nih.gov/pubmed/28945287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/em.22137 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|